Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO
FT News Briefing
00:00
Intro
This chapter explores European pharmaceutical companies' push for liability protections amid rapid vaccine development for COVID-19, highlighting the associated risks. It also examines the surge in U.S. homebuilder stocks fueled by low mortgage rates, showcasing a thriving market during the pandemic.
Play episode from 00:00
Transcript
